| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Harrow Health Inc (NASDAQ: HROW)
HROW Technical Analysis
5
| As on 9th Jun 2023 HROW STOCK Price closed @ 20.26 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 8.24 & Strong Buy for SHORT-TERM with Stoploss of 8.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HROWSTOCK Price
| Open | 20.40 | Change | Price | % |
| High | 20.77 | 1 Day | -0.25 | -1.22 |
| Low | 20.12 | 1 Week | 0.15 | 0.75 |
| Close | 20.26 | 1 Month | -3.89 | -16.11 |
| Volume | 274300 | 1 Year | 11.68 | 136.13 |
| 52 Week High 28.08 | 52 Week Low 5.75 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| HROW Daily Charts |
HROW Intraday Charts |
Whats New @ Bazaartrend |
HROW Free Analysis |
|
|
HROW Important Levels Intraday
| RESISTANCE | 21.51 |
| RESISTANCE | 21.11 |
| RESISTANCE | 20.86 |
| RESISTANCE | 20.61 |
| SUPPORT | 19.91 |
| SUPPORT | 19.66 |
| SUPPORT | 19.41 |
| SUPPORT | 19.01 |
HROW Forecast May 2024
| 4th UP Forecast | 24.04 |
| 3rd UP Forecast | 22.83 |
| 2nd UP Forecast | 22.08 |
| 1st UP Forecast | 21.33 |
| 1st DOWN Forecast | 19.19 |
| 2nd DOWN Forecast | 18.44 |
| 3rd DOWN Forecast | 17.69 |
| 4th DOWN Forecast | 16.48 |
HROW Weekly Forecast
| 4th UP Forecast | 22.09 |
| 3rd UP Forecast | 21.50 |
| 2nd UP Forecast | 21.14 |
| 1st UP Forecast | 20.78 |
| 1st DOWN Forecast | 19.74 |
| 2nd DOWN Forecast | 19.38 |
| 3rd DOWN Forecast | 19.02 |
| 4th DOWN Forecast | 18.43 |
HROW Forecast2024
| 4th UP Forecast | 64.29 |
| 3rd UP Forecast | 50.17 |
| 2nd UP Forecast | 41.44 |
| 1st UP Forecast | 32.71 |
| 1st DOWN Forecast | 7.81 |
| 2nd DOWN Forecast | -0.92 |
| 3rd DOWN Forecast | -9.65 |
| 4th DOWN Forecast | -23.77 |
Harrow Health Inc ( NASDAQ USA Symbol : HROW )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HROW Business Profile
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and Visionology, a membership-based online eye health and medication platform. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was founded in 1998 and is headquartered in San Diego, California. Address: 102 Woodmont Boulevard, Nashville, TN, United States, 37205
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service